awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q54478541-2AF9D7FB-274D-45C0-B569-E6BF88388F14
Q54478541-2AF9D7FB-274D-45C0-B569-E6BF88388F14
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54478541-2AF9D7FB-274D-45C0-B569-E6BF88388F14
Phase I study of lonafarnib (SCH66336) in combination with trastuzumab plus paclitaxel in Her2/neu overexpressing breast cancer: EORTC study 16023.
P2860
Q54478541-2AF9D7FB-274D-45C0-B569-E6BF88388F14
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54478541-2AF9D7FB-274D-45C0-B569-E6BF88388F14
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1cf68f9de350752b25d4337ae1019632a4c7d74d
P2860
New targets for therapy in breast cancer: farnesyltransferase inhibitors.